technical update, page-149

Come on Traderboy that is complete nonsense, ADO do not have the ongoing costs of PBT and have a far more diversified approach, There will be huge disappointment if BBI and Philips fail to sign (obviously the massive rise in SP has been off the back of speculation around them), but now their profile has been raised and the informed will want to stick with them. We've got years worth of working capital and increasing revenue streams from outside of the mega deals, not only that but our product has been proven time and again to work and outperform the status quo. ADO is not at all like a drug discovery company, I for one would move to massively increase my position if ADO fell by 50% or more.